| 1.8 |
7.0 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 1.6 |
4.8 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 1.2 |
4.7 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 1.1 |
3.4 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 1.0 |
6.2 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.9 |
2.8 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.9 |
4.4 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.9 |
8.7 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.8 |
6.0 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.7 |
11.9 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.6 |
3.7 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.6 |
3.5 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.6 |
2.3 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.6 |
1.7 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.6 |
1.7 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 0.6 |
1.7 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.5 |
1.6 |
GO:1904742 |
protein poly-ADP-ribosylation(GO:0070212) regulation of telomeric DNA binding(GO:1904742) |
| 0.5 |
1.4 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.5 |
1.8 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.5 |
0.5 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.4 |
1.8 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.4 |
1.7 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.4 |
1.7 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.4 |
1.2 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.4 |
1.6 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.4 |
8.7 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.4 |
1.1 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.4 |
1.8 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.4 |
2.1 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.4 |
1.4 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.3 |
1.7 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.3 |
1.0 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.3 |
2.2 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.3 |
0.9 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.3 |
1.9 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.3 |
0.8 |
GO:2001139 |
negative regulation of postsynaptic membrane organization(GO:1901627) negative regulation of dendritic spine maintenance(GO:1902951) negative regulation of phospholipid efflux(GO:1902999) regulation of lipid transport across blood brain barrier(GO:1903000) negative regulation of lipid transport across blood brain barrier(GO:1903001) positive regulation of lipid transport across blood brain barrier(GO:1903002) negative regulation of phospholipid transport(GO:2001139) |
| 0.3 |
1.3 |
GO:0021856 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
| 0.3 |
0.8 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.3 |
0.8 |
GO:0008228 |
opsonization(GO:0008228) modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.3 |
2.7 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.3 |
2.9 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.3 |
0.8 |
GO:0009838 |
abscission(GO:0009838) positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.3 |
1.0 |
GO:0010991 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.3 |
1.0 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.2 |
0.7 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.2 |
1.2 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.2 |
1.1 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.2 |
1.1 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.2 |
4.3 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.2 |
1.0 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.2 |
1.0 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
| 0.2 |
0.6 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.2 |
0.8 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.2 |
0.7 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 |
0.7 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.2 |
0.5 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.2 |
0.7 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.2 |
1.5 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 |
1.3 |
GO:0002488 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
| 0.2 |
1.1 |
GO:0042518 |
negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
| 0.1 |
0.4 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
0.6 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.1 |
0.3 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
0.8 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.1 |
0.4 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.1 |
0.7 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.1 |
2.8 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.1 |
0.6 |
GO:0090310 |
negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.1 |
0.6 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 |
1.4 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.1 |
0.8 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
0.3 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 |
1.1 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.1 |
0.5 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
0.5 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.1 |
0.5 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 |
2.2 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.1 |
0.4 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.1 |
0.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.6 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 |
0.9 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.6 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
1.0 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.9 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 |
1.2 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.4 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.1 |
0.3 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
1.6 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 |
0.2 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
0.4 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 |
0.4 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
1.1 |
GO:0061050 |
regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
| 0.1 |
2.0 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.1 |
0.3 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.8 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.1 |
0.5 |
GO:0007351 |
blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.1 |
1.1 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.3 |
GO:0072362 |
regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.1 |
1.0 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.9 |
GO:0043407 |
negative regulation of MAP kinase activity(GO:0043407) |
| 0.1 |
0.3 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.1 |
0.2 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.2 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.1 |
0.6 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
1.7 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.1 |
3.5 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 |
1.1 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.1 |
0.7 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.1 |
2.6 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
0.3 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.1 |
2.1 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.9 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.1 |
0.6 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.1 |
0.8 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.1 |
0.3 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.1 |
2.0 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.1 |
1.3 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.1 |
1.6 |
GO:0021952 |
central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.1 |
0.4 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.1 |
0.4 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.3 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 |
1.9 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.4 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.4 |
GO:1901844 |
regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 0.0 |
0.2 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.0 |
0.3 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 |
2.0 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.0 |
0.4 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.0 |
1.0 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.0 |
0.4 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.0 |
0.4 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.0 |
3.7 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.0 |
1.5 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.0 |
0.4 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.0 |
1.3 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.0 |
1.5 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.3 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 |
0.7 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.0 |
1.5 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.0 |
1.1 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.0 |
0.2 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
2.3 |
GO:0015807 |
L-amino acid transport(GO:0015807) |
| 0.0 |
0.4 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.0 |
0.4 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.0 |
0.1 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.0 |
0.6 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.5 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.5 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.8 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 |
0.5 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.0 |
0.3 |
GO:0022410 |
circadian sleep/wake cycle process(GO:0022410) regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
| 0.0 |
4.2 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
| 0.0 |
0.4 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 |
4.0 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.0 |
0.1 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.0 |
0.1 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.0 |
2.2 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
0.5 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.2 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.0 |
0.1 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.0 |
0.1 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.0 |
0.9 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.0 |
0.3 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.0 |
0.2 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.0 |
0.7 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
2.5 |
GO:0098780 |
mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
| 0.0 |
0.3 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
2.3 |
GO:0046488 |
phosphatidylinositol metabolic process(GO:0046488) |
| 0.0 |
1.5 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 |
0.7 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
0.1 |
GO:0061153 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.0 |
0.1 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.0 |
0.0 |
GO:0010871 |
negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.0 |
0.5 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.0 |
0.2 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 |
0.0 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.0 |
0.2 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
0.6 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.0 |
0.5 |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.0 |
0.2 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
1.0 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.1 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.0 |
0.0 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.0 |
0.6 |
GO:0000079 |
regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.0 |
0.1 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.0 |
0.4 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
1.0 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.5 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.0 |
0.4 |
GO:1900046 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
